ML18162A117

Shine Medical Technologies Acknowledgment of Receipt of 2016 Annual Financial Report

ML18162A117
Person / Time
Site:	SHINE Medical Technologies
Issue date:	06/18/2018
From:	Steven Lynch Research and Test Reactors Licensing Projects Branch
To:	Piefer G SHINE Medical Technologies
Lynch S, NRR/DLP, 415-1524
Shared Package
ML18162A116 -Pkg.	List: ML18162A117 ML18162A118
References
EPID L-2017-PMP-0014
Download: ML18162A117 (3)

Text

June 18, 2018 Gregory Piefer, Ph.D.

Chief Executive Officer SHINE Medical Technologies, Inc.

101 E. Milwaukee Street, Suite 600 Janesville, WI 53545

SUBJECT:

SHINE MEDICAL TECHNOLOGIES, INC. - ACKNOWLEDGMENT OF RECEIPT OF ANNUAL FINANCIAL REPORT (EPID NO. L-2017-PMP-0014)

Dear Dr. Piefer:

By letter dated May 11, 2017 (Agencywide Documents Access and Management System Accession No. ML17135A337), SHINE Medical Technologies, Inc. (SHINE) submitted to the U.S. Nuclear Regulatory Commission (NRC or Commission) its annual financial report, including certified financial statements, in accordance with the requirements of Title 10 of the Code of Federal Regulations (10 CFR) 50.71, Maintenance of records, making of reports, paragraph (b).

Pursuant to 10 CFR Part 50, Domestic Licensing of Production and Utilization Facilities, the NRC considers the financial qualifications of applicants and licensees during the initial licensing reviews of construction permit and operating license applications. Once a construction permit or operating license has been issued, the NRC requires certain permit holders and certain licensees to submit their annual financial reports, in accordance with 10 CFR 50.71(b). While these annual financial reports are submitted for informational purposes, the NRC keeps these reports available for inspection when considering a permit holders or a licensees financial qualifications to conduct activities authorized under its 10 CFR Part 50 construction permit or operating license.

The NRC issued Construction Permit No. CPMIF-001 on February 29, 2016, finding, in part, that SHINE was financially qualified to design and construct its proposed medical isotope facility in accordance with the Commissions regulations set forth in 10 CFR Chapter I based on the information provided in SHINEs preliminary safety analysis report supporting its construction permit application. As of the writing of this letter, SHINE has neither initiated construction of its proposed facility nor has it submitted any additional design information as part of an operating license application for NRC review under Docket No. 50-608.

Therefore, based upon the status of activities authorized under Construction Permit No. CPMIF-001 and the status of applications submitted under Docket No. 50-608, the NRC has determined that no action is necessary on SHINEs annual financial report at this time.

However, pursuant to 10 CFR 50.33, Contents of applications; general information, paragraph (f)(5), the Commission may request that SHINE submit additional or more detailed information respecting its financial arrangements and status of funds if the Commission considers this information appropriate. This may include information regarding [SHINEs] ability

G. Piefer to continue the conduct of the activities authorized by, Construction Permit No. CPMIF-001 or by an operating license applied for under Docket No. 50-608.

If you have any questions, please contact me at 301-415-1524, or by electronic mail at Steven.Lynch@nrc.gov.

Sincerely,

/RA/

Steven T. Lynch, Project Manager Research and Test Reactors Licensing Branch Division of Licensing Projects Office of Nuclear Reactor Regulation Docket No. 50-608

ML18162A117 Ltr.; ML18162A118 Withholding Ltr.;

ML18162A116 Pkg. *concurred via email NRR-088 OFFICE NRR/DLP/PRLB/PM NRR/DLP/PROB/LA* NRR/DLP/PRLB/BC NRR/DLP/PRLB/PM NAME SLynch NParker AAdams SLynch DATE 06/08/2018 6/13/18 6/15/18 6/18/18